-
公开(公告)号:US11944611B2
公开(公告)日:2024-04-02
申请号:US16512166
申请日:2019-07-15
发明人: Laura Elizabeth Bauer , Anna Chiu , Eric M. Gorman , Andrew Stephen Mulato , Martin Sunkwang Rhee , Charles William Rowe , Scott P. Sellers , Dimitrios Stefanidis , Winston C. Tse , Stephen R. Yant , Dana J. Levine
IPC分类号: A61K31/4439 , A61K9/00 , A61K9/48 , A61K31/34 , A61K31/4418 , A61K31/536 , A61K31/5365 , A61K31/685 , A61P31/18
CPC分类号: A61K31/4439 , A61K9/0019 , A61K9/0053 , A61K9/4825 , A61K31/34 , A61K31/4418 , A61K31/536 , A61K31/5365 , A61K31/685 , A61P31/18
摘要: The present disclosure relates to compounds of Formula (Ia) and (Ib):
or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.-
公开(公告)号:US20240316018A1
公开(公告)日:2024-09-26
申请号:US18588730
申请日:2024-02-27
发明人: Laura Elizabeth Bauer , Anna Chiu , Eric M. Gorman , Andrew Stephen Mulato , Martin Sunkwang Rhee , Charles William Rowe , Scott P. Sellers , Dimitrios Stefanidis , Winston C. Tse , Stephen R. Yant , Dana J. Levine
IPC分类号: A61K31/4439 , A61K9/00 , A61K9/48 , A61K31/34 , A61K31/4418 , A61K31/536 , A61K31/5365 , A61K31/685 , A61P31/18
CPC分类号: A61K31/4439 , A61K9/0019 , A61K9/0053 , A61K9/4825 , A61K31/34 , A61K31/4418 , A61K31/536 , A61K31/5365 , A61K31/685 , A61P31/18
摘要: The present disclosure relates to compounds of Formula (Ia) and (Ib):
or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.-
公开(公告)号:US20200038389A1
公开(公告)日:2020-02-06
申请号:US16512166
申请日:2019-07-15
发明人: Laura Elizabeth Bauer , Anna Chiu , Eric M. Gorman , Andrew Stephen Mulato , Martin Sunkwang Rhee , Charles William Rowe , Scott P. Sellers , Dimitrios Stefanidis , Winston C. Tse , Stephen R. Yant
IPC分类号: A61K31/4439 , A61P31/18 , A61K31/685 , A61K31/536 , A61K31/5365 , A61K31/34 , A61K31/4418 , A61K9/00 , A61K9/48
摘要: The present disclosure relates to compounds of Formula (Ia) and (Ib): or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
-
-